Exciting new cancer drug kinder than chemotherapy
Arthur, 11, was one of the first in the UK to try blinatumomab, for his type of blood cancer.
Similar Posts
I noticed a bulging lump sensation in my vagina
When Natashja Wilson noticed symptoms of pelvic organ prolapse she had no idea what was happening.
JN.1 variant no more severe than other COVID-19 strains, CDC says
Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…
Daylesford Organic recall biscuits over moth larvae
Food Standards Agency’s Head of Incidents, Rajwinder Ubhi said: “Daylesford Organic Rye, Spelt & Raisin Crispbreads and Savoury Biscuit Selection have been recalled by the business because the Crispbreads have been contaminated by moth larvae, making the products unsafe to eat.
King Charles III to be treated for prostate condition, know the signs and symptoms of the cancer found in men
Prostate cancer is the most common cancer found in men. King Charles III is one public figure who has been open about his prostate procedure. Buckingham Palace announced that the king would receive hospital treatment for an enlarged prostate, a condition also very common in men. KING CHARLES II TO UNDERGO ‘CORRECTIVE PROCEDURE’ NEXT WEEK…
Gene therapy breakthrough restores hearing in some deaf children
Gene therapy has successfully restored hearing in some children born with inherited deafness, health officials say. A study in China and another at the Children’s Hospital of Philadelphia documented significant improvements in hearing in treated children. Cochlear implants are commonly used for children with hereditary deafness, but gene therapy offers a potential treatment. Gene therapy…
We like health-care stocks in 2024 despite presidential election year weakness
As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason to believe this year that many health-related stocks, led by Eli Lilly , could defy historical convention. The S & P 500 Health Care Sector…